A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.
By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback